Event-Driven Stocks

Telix Pharmaceuticals Ltd

TLXNasdaq

Healthcare · Pharmaceutical Preparations · C3 · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

FDA-approved drugs

openFDA · most recent
  • ILLUCCIXDec 17, 2021

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026217,2981.9-19.6%
Apr 30, 2026270,0881.5-30.9%
Apr 15, 2026390,7171.6+27.7%
Mar 31, 2026306,0001.2+69.2%
Mar 13, 2026180,8321.0-51.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Recent SEC filings

All filings ↗

Event-driven situations (1)